A mechanism proposed to explain the rise in oxidative stress during aging

Journal of Anti-Aging Medicine

Volumn 1, Issue 1, 1998, Pages 53-66

  De Grey, Aubrey D N J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA; VERTEBRATA;

EID: 0002386563     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.1.1998.1.53     Document Type: Article

References (73)

1. Harman D: Aging: A theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
2. Harman D: The biologic clock: The mitochondria? J Am Geriatr Soc 1972;20:145-147.
3. Boffoli D, Scacco SC, Vergar R et al.: Decline with age of the respiratory chain activity in human skeletal muscle. Biochim Biophys Acta 1994;1226:73-82.
4. Sugiyama S, Takasawa M, Hayakawa M et al.: Changes in skeletal muscle, heart and liver mitochondrial electron transport activities in rats and dogs of various ages. Biochem Mol Biol Int 1993;30:937-944.
5. Syrovy I, and Gutmann E: Changes in speed of contraction and ATPase activity in striated muscle during old age. Exp Gerontol 1977;12:31-35.
6. Cortopassi GA, and Arnheim N: Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acids Res 1990;18:6927-6933.
7. Arnheim N, and Cortopassi G: Deleterious mitochondrial DNA mutations accumulate in aging human tissues. Mutat Res 1992;275:157-167.
8. Kadenbach B, Muenscher C, Frank V et al.: Human aging is associated with stochastic somatic mutations of mitochondrial DNA. Mutat Res 1995;338:161-172.
9. Pallotti F, Chen X, Bonilla E et al: Evidence that specific mtDNA point mutations may not accumulate in skeletal muscle during normal human aging. Am J Hum Genet 1996;59:591-602.
10. Corral-Debrinski M, Horton T, Lott MT et al.: Mitochondrial DNA deletions in human brain: Regional variability and increase with advanced age. Nat Genet 1992;2:324-329.
11. Cortopassi GA, Shibata D, Soong NW et al.: A pattern of accumulation of a somatic deletion of mitochondrial DNA in aging human tissues. Proc Natl Acad Sci USA 1992;89:7370-7374.
12. Miquel J, Economos AC, Fleming J et al.: Mitochondrial role in cell aging. Exp Gerontol 1980;15:575-591.
13. Wallace DC: Mitochondrial DNA mutations and neuromuscular disease. Trends Genet 1989;5:9-13.
14. Wallace DC, Bohr VA, Cortopassi G et al.: Group report: The role of bioenergetics and mitochondrial DNA mutations in aging and age-related diseases, in Esser K, Martin GM: Molecular aspects of aging. Chichester, UK: Wiley, 1995:199-225.
15. Mueller-Hoecker J: Cytochrome c oxidase deficient cardiomyocytes in the human heart - An age-related phenomenon. A histochemical ultracytochemical study. Am J Pathol 1989;134:1167-1173.
16. Mueller-Hoecker J, Seibel P, Schneiderbanger K et al.: Different in situ hybridization patterns of mitochondrial DNA in cytochrome c oxidase-deficient extraocular muscle fibres in the elderly. Virchows Arch (A) 1993;422:7-15.
17. Oldfors A, Larsson NG, Holme E et al.: Mitochondrial DNA deletions and cytochrome c oxidase deficiency in muscle fibres. J Neurol Sci 1992;110:169-177.
18. Mueller-Hoecker J, Aust D, Napiwotzky J et al.: Defects of the respiratory chain in oxyphil and chief cells of the normal parathyroid and in hyperfunction. Hum Pathol 1996;27:532-541.
19. Mueller-Hoecker J, Aust D, Rohrbach H et al.: Defects of the respiratory chain in the normal human liver and in cirrhosis during aging. Hepatology 1997;26: 709-719.
20. Aspnes LE, Lee CM, Weindruch R et al.: Caloric restriction reduces fiber loss and mitochondrial abnormalities in aged rat muscle. FASEB J 1997;11:573-581.
21. th Annual Meeting: Abstract 71; Age (Omaha) 1997;20(4), in press.
22. de Grey ADNJ: A proposed refinement of the mitochondrial free radical theory of aging. BioEssays 1997;19:161-166.
23. Zhang C, Peters LE, Linnane AW et al.: Comparison of different quantitative PCR procedures in the analysis of the 4977-bp deletion in human mitochondrial DNA. Biochem Biophys Res Commun 1996;223: 450-455.
24. Anderson S, Bankier AT, Barrell BG et al.: Sequence and organization of the human mitochondrial genome. Nature 1981;290:457-465.
25. Liu VW, Zhang C, Linnane AW et al.: Quantitative allele-specific PCR: Demonstration of age-associated accumulation in human tissues of the A → G mutation at nucleotide 3243 in mitochondrial DNA. Hum Mutat 1997;9:265-271.
26. Fahy E, Nazarbaghi R, Zomorrodi M et al.: Multiplex fluorescence-based primer extension method for quantitative mutation analysis of mitochondrial DNA and its diagnostic application for Alzheimer's disease. Nucleic Acids Res 1997;25:3102-3109.
27. Gershon D, and de Grey ADNJ: Correspondence arising from BioEssays 19:161-166. BioEssays 1997;19: 533-534.
28. Mueller-Hoecker J, Schaefer S, Link TA et al.: Defects of the respiratory chain in various tissues of old monkeys: A cytochemical-immunocytochemical study. Mech. Ageing Dev 1996;86:197-213.
29. King MP, and Attardi G: Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 1989;246:500-503.
30. 0 human Namalwa cells lacking oxidative phosphorylation can be sustained by redox compounds potassium ferricyanide or coenzyme Q10 putatively acting through the plasma membrane oxidase. Biochem Mol Biol Int 1993;31:997-1005.
31. Crane FL, and Loew H: NADH oxidation in liver and fat cell plasma membranes. FEBS Lett 1976;68: 153-156.
32. Crane FL, Sun IL, Clark MG et al.: Transplasma-membrane redox systems in growth and development. Biochim Biophys Acta 1985;811:233-264.
33. 0 cells. J Biol Chem 1994;269:30097-30100.
34. Clark MG, Partick EJ, Patten GS et al.: Evidence for the extracellular reduction of ferricyanide by rat liver. A trans-plasma membrane redox system. Biochem J 1981;200:565-572.
35. Vaillant F, Larm JA, McMullen GL et al.: Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators. J Bioenerg Biomembr 1996;28: 531-540.
36. Stralin P, Karlsson K, Johansson BO et al.: The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995;15:2032-2036.
37. Kappus H: Lipid peroxidation: Mechanisms, analysis, enzymology and biological relevance, in Sies H: Oxidative stress. New York: Academic Press, 1985:152-195.
38. Aruoma OI, and Halliwell B: Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron. Are lactoferrin and transferrin promoters of hydroxyl-radical generation? Biochem J 1987;241:273-278.
39. Loew H, Grebing C, Lindgren A et al.: Involvement of transferrin in the reduction of iron by the transplasma membrane electron transport system. J Bioenerg Biomembr 1987;19:535-549.
40. Samokyszyn VM, Miller DM, Reif DW et al.: Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin. J Biol Chem 1989;264: 21-26.
41. Miller YI, Felikman Y, and Shaklai N: The involvement of low-density lipoprotein in hemin transport potentiates peroxidative damage. Biochim Biophys Acta 1995;1272:119-127.
42. Morgan WT, Liem HH, Sutor RP et al.: Transfer of heme from heme-albumin to hemopexin. Biochim Biophys Acta 1976;444:435-445.
43. Miller YI, Smith A, Morgan WT et al.: Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. Biochemistry 1996; 35:13112-13117.
44. Nourooz-Zadeh J, Tajaddini-Sarmadi J, Ling KL et al.: Low-density lipoprotein is the major carrier of lipid hydroperoxides in plasma. Relevance to determination of total plasma lipid hydroperoxide concentrations. Biochem J 1996;313:781-786.
45. Steinberg D: Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997;272: 20963-20966.
46. Cushing SD, Berliner JA, Valente AJ et al.: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 1990;87:5134-5138.
47. Kodama T, Freeman M, Rohrer L et al.: Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 1990;343: 531-535.
48. van Berkel TJ, de Rijke YB, and Kruijt JK: Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem 1991;266:2282-2289.
49. Kawase M, Kondoh C, Matsumoto S et al.: Contents of D-lactate and its related metabolites as well as enzyme activities in the liver, muscle and blood plasma of aging rats. Mech Ageing Dev 1995;84:55-63.
50. Davies MJ, Fu S, and Dean RT: Protein hydroperoxides can give rise to reactive free radicals. Biochem J 1995;305:643-649.
51. Trigatti BL, and Gerber GE: A direct role for serum albumin in the cellular uptake of long-chain fatty acids. Biochem J 1995;308:155-159.
52. Esworthy RS, Chu FF, Geiger P et al.: Reactivity of plasma glutathione peroxidase with hydroperoxide substrates and glutathione. Arch Biochem Biophys 1993;307:29-34.
53. Goldenberg H, Crane LF, Moore DJ: NADH oxidoreductase of mouse liver plasma membranes. J. Biol. Chem. 1979;254:2491-2498.
54. Karlsson K, and Marklund SL: Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J 1987;242:55-59.
55. Steinbrecher UP, Parthasarathy S, Leake DS et al.: Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 1984;81:3883-3887.
56. Boveris A, and Chance B: The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 1973;134: 707-716.
57. Berlett BS, and Stadtman ER: Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997;272:20313-20316.
58. Taylor RW, Chinnery PF, Turnbull DM et al.: Selective inhibition of mutant human mitochondrial DNA replication in vitro by peptide nucleic acids. Nature Genet 1997;15:212-215.
59. Seibel P, Trappe J, Villani G et al.: Transfection of mitochondria: Strategy towards a gene therapy of mitochondrial DNA diseases. Nucleic Acids Res 1995;23:10-17.
60. Nagley P, Farrell LB, Gearing DP et al.: Assembly of functional proton-translocating ATPase complex in yeast mitochondria with cytoplasmically synthesized subunit 8, a polypeptide normally encoded within the organelle. Proc Natl Acad Sci USA 1988;85:2091-2095.
61. Lander ES, and Lodish H: Mitochondrial diseases: Gene mapping and gene therapy. Cell 1990;61:925-926.
62. Hoeben P: Possible reversal of ageing and other mitochondrial deficiencies through retroviral transfection of mitochondrially encoded proteins to the nucleus. Med Hypotheses 1993;41:131-133.
63. Papa S, Scacco S, Schliebs M et al.: Mitochondrial diseases and aging. Mol Aspects Med 1996;17:529-533.
64. Taylor RW, Chinnery PF, Clark KM et al.: Treatment of mitochondrial disease. J Bioenerg Biomembr 1997;29:195-205.
65. Murphy MP: Selective targeting of bioactive compounds to mitochondria. Trends Biotechnol 1997;15: 326-330.
66. Galanis M, Devenish RJ, and Nagley P: Duplication of leader sequence for protein targeting to mitochondria leads to increased import efficiency. FEBS Lett 1991;282:425-430.
67. Claros MG, Perea J, Shu Y et al.: Limitations to in vivo import of hydrophobic proteins into yeast mitochondria. The case of a cytoplasmically synthesised apocytochrome b. Eur J Biochem 1996;228:762-771.
68. Polyak K, Xia Y, Zweier JL et al.: A model for in vivo-induced apoptosis. Nature 1997;389:300-305.
69. Pierzchalaski P, Reiss K, Cheng W et al.: p53 induces myocyte apoptosis via the activation of the reninangiotensin system. Exp Cell Res 1997;234:57-65.
70. Frei B, England L, and Ames BN: Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA 1989;86:6377-6381.
71. Larm JA, Wolvetang EJ, Vaillant F et al.: Increase of plasma-membrane oxidoreductase activity is not correlated with the production of extracellular superoxide radicals in human Namalwa cells. Protoplasma 1995;184:173-180.
72. Nishinaka Y, Aramaki Y, Yoshida H et al.: A new sensitive chemiluminescence probe, L-012, for measuring the production of superoxide anion by cells. Biochem Biophys Res Commun 1993;193:554-559.
73. Moore DJ: Hormone- and growth factor-stimulated NADH oxidase. J. Bioenerg. Biomembr. 1994;26:421-433.